Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
UBE2W - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RSBN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TNFRSF18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TP73 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR492 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
KLK12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
JKAMP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAA20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
USO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CATSPER1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TCEAL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HSPE1-MOB4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC284080 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
MOB1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SUZ12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SAR1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CPSF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on